Literature DB >> 3800529

Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations.

J I Kennedy, J L Myers, V J Plumb, J D Fulmer.   

Abstract

We have studied 15 patients with amiodarone pulmonary toxicity and compared them with five amiodarone patients without evidence of toxic effect. Six of 15 patients who had toxic reactions presented with an acute illness that resembled an infectious disease. While diffuse interstitial disease was frequent on chest roentgenogram, seven of 15 had airspace opacities, and five had well-localized infiltrates. Physiologic changes were not uniformly found. An interstitial pneumonia with foamy alveolar macrophages was the most common pathologic finding. Foamy macrophages were also present in three of five nontoxic patients. Three of three patients who had toxic reactions, and two of five patients without toxic reactions had lamellated inclusion bodies by electron microscopy. We conclude that all features of amiodarone toxicity are protean, and it may mimic infectious diseases. While pathologic changes are often characteristic, neither foamy alveolar macrophages nor lamellated cytoplasmic inclusions reliably distinguish toxic from nontoxic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800529     DOI: 10.1001/archinte.147.1.50

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

Review 1.  Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.

Authors:  Fumikazu Sakai; Takeshi Johkoh; Masahiko Kusumoto; Hiroaki Arakawa; Masahiro Takahashi
Journal:  Int J Clin Oncol       Date:  2012-11-10       Impact factor: 3.402

Review 2.  Interstitial lung disease: progress and problems.

Authors:  S J Bourke
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

3.  Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

Authors:  B D Wilson; M L Lippmann
Journal:  Lung       Date:  1996       Impact factor: 2.584

4.  Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy.

Authors:  S Piciucchi; M Romagnoli; M Chilosi; C Bigliazzi; A Dubini; B Beomonte Zobel; G Gavelli; A Carloni; V Poletti
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

5.  Amiodarone-induced pulmonary toxicity in the rat.

Authors:  B D Wilson; A J Jaworski; M E Donner; M L Lippmann
Journal:  Lung       Date:  1989       Impact factor: 2.584

Review 6.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 7.  Amiodarone pulmonary toxicity.

Authors:  N Wolkove; M Baltzan
Journal:  Can Respir J       Date:  2009 Mar-Apr       Impact factor: 2.409

8.  Effects of cigarette smoking on iodine 123 N-isopropyl-p-iodoamphetamine clearance from the lung.

Authors:  K Kato; S Harada; T Takahashi; S Katsuragawa; T Yanagisawa
Journal:  Eur J Nucl Med       Date:  1991

9.  Amiodarone hepatotoxicity with absent phospholipidosis and steatosis: a case report and review of amiodarone toxicity in various organs.

Authors:  Adela Cimic; Joseph Sirintrapun
Journal:  Case Rep Pathol       Date:  2013-05-20

10.  Assessment of lung toxicity caused by bleomycin and amiodarone by Tc-99m HMPAO lung scintigraphy in rats.

Authors:  G Gumuser; K Vural; T Varol; Y Parlak; I Tuglu; G Topal; E Sayit
Journal:  Ann Nucl Med       Date:  2013-04-05       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.